Parcion Private Wealth LLC Raises Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Parcion Private Wealth LLC increased its holdings in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 22.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,295 shares of the healthcare conglomerate’s stock after purchasing an additional 239 shares during the quarter. Parcion Private Wealth LLC’s holdings in UnitedHealth Group were worth $682,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the business. Kraft Davis & Associates LLC raised its holdings in UnitedHealth Group by 3.4% in the 3rd quarter. Kraft Davis & Associates LLC now owns 577 shares of the healthcare conglomerate’s stock worth $294,000 after purchasing an additional 19 shares during the period. Iron Horse Wealth Management LLC raised its holdings in shares of UnitedHealth Group by 1.6% during the third quarter. Iron Horse Wealth Management LLC now owns 1,217 shares of the healthcare conglomerate’s stock valued at $614,000 after acquiring an additional 19 shares during the last quarter. Secure Asset Management LLC raised its holdings in shares of UnitedHealth Group by 0.8% during the third quarter. Secure Asset Management LLC now owns 2,456 shares of the healthcare conglomerate’s stock valued at $1,238,000 after acquiring an additional 19 shares during the last quarter. Bensler LLC raised its holdings in shares of UnitedHealth Group by 0.3% during the third quarter. Bensler LLC now owns 7,293 shares of the healthcare conglomerate’s stock valued at $3,677,000 after acquiring an additional 19 shares during the last quarter. Finally, Texas Capital Bancshares Inc TX raised its holdings in shares of UnitedHealth Group by 1.1% during the third quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock valued at $855,000 after acquiring an additional 19 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 6.4 %

NYSE:UNH opened at $458.16 on Wednesday. The firm has a market cap of $422.39 billion, a PE ratio of 19.22, a price-to-earnings-growth ratio of 1.33 and a beta of 0.54. The stock has a fifty day moving average price of $500.89 and a 200 day moving average price of $518.93. UnitedHealth Group Incorporated has a 12-month low of $445.68 and a 12-month high of $554.70. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.62.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share for the quarter, beating analysts’ consensus estimates of $5.98 by $0.18. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The company had revenue of $94.43 billion for the quarter, compared to analysts’ expectations of $92.13 billion. During the same period last year, the firm earned $5.34 earnings per share. UnitedHealth Group’s quarterly revenue was up 14.1% on a year-over-year basis. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.82 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.64%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 31.54%.

Insider Transactions at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently commented on the company. Oppenheimer reaffirmed an “outperform” rating and issued a $610.00 price target on shares of UnitedHealth Group in a report on Wednesday, January 17th. Piper Sandler cut their price target on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating for the company in a report on Wednesday, January 17th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $596.00 price target on shares of UnitedHealth Group in a report on Thursday, February 29th. Barclays initiated coverage on UnitedHealth Group in a research report on Wednesday, March 6th. They issued an “overweight” rating and a $551.00 price objective for the company. Finally, Bank of America reiterated a “buy” rating and issued a $675.00 price objective on shares of UnitedHealth Group in a research report on Thursday, March 7th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average price target of $579.33.

Get Our Latest Research Report on UnitedHealth Group

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Recommended Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.